Beijing Scitop Bio-tech Co., Ltd.

SZSE:300858 Rapporto sulle azioni

Cap. di mercato: CN¥4.1b

Beijing Scitop Bio-tech Crescita futura

Future criteri di controllo 5/6

Beijing Scitop Bio-tech is forecast to grow earnings and revenue by 42.6% and 36% per annum respectively while EPS is expected to grow by 42.6% per annum.

Informazioni chiave

42.6%

Tasso di crescita degli utili

42.6%

Tasso di crescita dell'EPS

Food crescita degli utili22.1%
Tasso di crescita dei ricavi36.0%
Rendimento futuro del capitale proprion/a
Copertura analitica

Low

Ultimo aggiornamento05 May 2024

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Beijing Scitop Bio-tech Co., Ltd.'s (SZSE:300858) Earnings Haven't Escaped The Attention Of Investors

Sep 27
Beijing Scitop Bio-tech Co., Ltd.'s (SZSE:300858) Earnings Haven't Escaped The Attention Of Investors

Weak Statutory Earnings May Not Tell The Whole Story For Beijing Scitop Bio-tech (SZSE:300858)

Aug 27
Weak Statutory Earnings May Not Tell The Whole Story For Beijing Scitop Bio-tech (SZSE:300858)

Beijing Scitop Bio-tech (SZSE:300858) Will Pay A Smaller Dividend Than Last Year

Jun 29
Beijing Scitop Bio-tech (SZSE:300858) Will Pay A Smaller Dividend Than Last Year

Investor Optimism Abounds Beijing Scitop Bio-tech Co., Ltd. (SZSE:300858) But Growth Is Lacking

Apr 18
Investor Optimism Abounds Beijing Scitop Bio-tech Co., Ltd. (SZSE:300858) But Growth Is Lacking

Beijing Scitop Bio-tech (SZSE:300858) Is Reinvesting At Lower Rates Of Return

Mar 22
Beijing Scitop Bio-tech (SZSE:300858) Is Reinvesting At Lower Rates Of Return

Previsioni di crescita degli utili e dei ricavi

SZSE:300858 - Stime future degli analisti e dati finanziari passati (CNY Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/2025504166N/A1381
12/31/2024403123N/A1081
9/30/202430193-59134N/A
6/30/202429797-77112N/A
3/31/202428692-88113N/A
12/31/202329993-71107N/A
9/30/202332295-64128N/A
6/30/2023352105-37113N/A
3/31/202335510630135N/A
1/1/202336911064148N/A
9/30/2022360111113150N/A
6/30/2022354110144173N/A
3/31/202237011158128N/A
12/31/202136511043110N/A
9/30/20213641091172N/A
6/30/2021366103-159N/A
3/31/20213611037187N/A
12/31/2020339974567N/A
9/30/2020334996895N/A
6/30/2020313924280N/A
3/31/2020315953392N/A
12/31/2019308935298N/A
6/30/20193059060112N/A
3/31/2019296842284N/A
1/1/201931892-690N/A
12/31/201728471N/A84N/A
12/31/201626112N/A33N/A
12/31/201518535N/A3N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: 300858's forecast earnings growth (42.6% per year) is above the savings rate (2.9%).

Guadagni vs Mercato: 300858's earnings (42.6% per year) are forecast to grow faster than the CN market (25.8% per year).

Guadagni ad alta crescita: 300858's earnings are expected to grow significantly over the next 3 years.

Ricavi vs Mercato: 300858's revenue (36% per year) is forecast to grow faster than the CN market (14% per year).

Ricavi ad alta crescita: 300858's revenue (36% per year) is forecast to grow faster than 20% per year.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Insufficient data to determine if 300858's Return on Equity is forecast to be high in 3 years time

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y